These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 29656183
1. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ. Han M, Gao H, Ju P, Gao MQ, Yuan YP, Chen XH, Liu KL, Han YT, Han ZW. Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183 [Abstract] [Full Text] [Related]
2. Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway. Han M, Gao H, Xie J, Yuan YP, Yuan Q, Gao MQ, Liu KL, Chen XH, Han YT, Han ZW. Acta Pharmacol Sin; 2019 May; 40(5):666-676. PubMed ID: 30218072 [Abstract] [Full Text] [Related]
3. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. Chen K, Zhang S, Ji Y, Li J, An P, Ren H, Liang R, Yang J, Li Z. PLoS One; 2013 May; 8(9):e72927. PubMed ID: 24039823 [Abstract] [Full Text] [Related]
4. Hispidulin inhibits proliferation, migration, and invasion by promoting autophagy via regulation of PPARγ activation in prostate cancer cells and xenograft models. Wang Y, Guo S, Jia Y, Yu X, Mou R, Li X. Biosci Biotechnol Biochem; 2021 Mar 24; 85(4):786-797. PubMed ID: 33590833 [Abstract] [Full Text] [Related]
5. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y, Lo CM, Teoh N, Farrell GC, Sung JJ, Yu J. Br J Cancer; 2012 Apr 24; 106(9):1486-94. PubMed ID: 22472882 [Abstract] [Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression. Cao LQ, Shao ZL, Liang HH, Zhang DW, Yang XW, Jiang XF, Xue P. Cancer Lett; 2015 Apr 01; 359(1):127-35. PubMed ID: 25592041 [Abstract] [Full Text] [Related]
7. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation. Gao H, Gao MQ, Peng JJ, Han M, Liu KL, Han YT. Acta Pharmacol Sin; 2017 Dec 01; 38(12):1618-1631. PubMed ID: 29119970 [Abstract] [Full Text] [Related]
8. The Effect of Hispidulin, a Flavonoid from Salvia plebeia, on Human Nasopharyngeal Carcinoma CNE-2Z Cell Proliferation, Migration, Invasion, and Apoptosis. Dai Y, Sun X, Li B, Ma H, Wu P, Zhang Y, Zhu M, Li HM, Qin M, Wu CZ. Molecules; 2021 Mar 14; 26(6):. PubMed ID: 33799348 [Abstract] [Full Text] [Related]
9. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y, Gao Q, Su C. Cancer Lett; 2015 Nov 01; 368(1):126-134. PubMed ID: 26259512 [Abstract] [Full Text] [Related]
10. APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways. Di T, Luo QY, Song JT, Yan XL, Zhang L, Pan WT, Guo Y, Lu FT, Sun YT, Xia ZF, Yang LQ, Qiu MZ, Yang DJ, Sun J. Int Immunopharmacol; 2024 Sep 30; 139():112615. PubMed ID: 39032475 [Abstract] [Full Text] [Related]
11. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS. Oncol Rep; 2007 Oct 30; 18(4):825-32. PubMed ID: 17786342 [Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1. Pang X, Wei Y, Zhang Y, Zhang M, Lu Y, Shen P. Cancer Sci; 2013 Jun 30; 104(6):672-80. PubMed ID: 23461356 [Abstract] [Full Text] [Related]
13. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma. Hsu HT, Sung MT, Lee CC, Kuo YJ, Chi CW, Lee HC, Hsia CY. Int J Mol Sci; 2016 Jul 29; 17(8):. PubMed ID: 27483249 [Abstract] [Full Text] [Related]
14. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells. Kim YW, Jang EJ, Kim CH, Lee JH. Chem Biol Interact; 2017 Jan 05; 261():108-117. PubMed ID: 27871897 [Abstract] [Full Text] [Related]
15. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration. Guo Y, Zhu H, Weng M, Chen B, Wang C, Sun L. Biomed Pharmacother; 2020 Aug 05; 128():110366. PubMed ID: 32526459 [Abstract] [Full Text] [Related]
16. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice. Xiao CL, Tao ZH, Guo L, Li WW, Wan JL, Sun HC, Wang L, Tang ZY, Fan J, Wu WZ. BMC Cancer; 2011 Apr 22; 11():150. PubMed ID: 21513518 [Abstract] [Full Text] [Related]
17. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer. Tang Q, Wu J, Zheng F, Hann SS, Chen Y. Cell Physiol Biochem; 2017 Apr 22; 41(1):339-357. PubMed ID: 28214826 [Abstract] [Full Text] [Related]
18. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. Pei T, Meng Q, Han J, Sun H, Li L, Song R, Sun B, Pan S, Liang D, Liu L. Oncotarget; 2016 Jul 12; 7(28):43475-43491. PubMed ID: 27259268 [Abstract] [Full Text] [Related]
19. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma. Choi Y, Oh ST, Won MA, Choi KM, Ko MJ, Seo D, Jeon TW, Baik IH, Ye SK, Park KU, Park IC, Jang BC, Seo JY, Lee YH. Biochem Biophys Res Commun; 2016 Sep 30; 478(4):1674-81. PubMed ID: 27592554 [Abstract] [Full Text] [Related]
20. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY. Liver Int; 2015 Apr 30; 35(4):1416-29. PubMed ID: 25066210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]